NASDAQ
Crescita Therapeutics Inc. (CRRTF) has a revenue compound annual growth rate of 6.17% over 5 years and 37.76% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.